Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease

BACKGROUND AND AIMS: Therapeutic drug monitoring [TDM] has proven to be effective for optimising anti-tumour necrosis factor [TNF] therapy in inflammatory bowel disease [IBD]. Nevertheless, the majority of data refer to infliximab and reactive testing or association studies. We aimed to compare the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Crohns Colitis
Main Authors: Papamichael, Konstantinos, Juncadella, Anna, Wong, Danny, Rakowsky, Shana, Sattler, Lindsey A, Campbell, James P, Vaughn, Byron P, Cheifetz, Adam S
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6939875/
https://ncbi.nlm.nih.gov/pubmed/30689771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjz018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados